Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA383010 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:The Genomic Landscape of Tuberous Sclerosis Complex
| PRJNA383009 | ENA
Project description:Genetic analysis of Tuberous Sclerosis Complex (TSC) hypomelanotic macules
| PRJNA352301 | ENA
Project description:Identification of potential pathogenic variant associated with tuberous sclerosis complex
| PRJNA659398 | ENA
Project description:Massive LINE1 retrotransposon Invasion in Tuberous Sclerosis Astrocytomas
| PRJNA244833 | ENA
Project description:Chordoma associated with tuberous sclerosis complex (TSC)
| PRJNA807369 | ENA
Project description:<p>In this study, we characterized the genomic landscape of tuberous sclerosis complex (TSC), a rare genetic disease causing multisystem growth of benign tumors and other hamartomatous lesions. We analyzed 127 human tissues, including 111 TSC-associated samples and 16 non-TSC negative controls, using multiple genomic platforms including whole exome sequencing, targeted sequencing of known disease-causative loci (<i>TSC1</i> and <i>TSC2</i>), mRNA sequencing, high-density SNP arrays, and DNA methylation arrays.</p>
| phs001357 | dbGaP
Project description:Kynureninase is a member of a large family of catalytically diverse but structurally homologous pyridoxal 5'-phosphate (PLP) dependent enzymes known as the aspartate aminotransferase superfamily or alpha-family. The Homo sapiens and other eukaryotic constitutive kynureninases preferentially catalyze the hydrolytic cleavage of 3-hydroxy-l-kynurenine to produce 3-hydroxyanthranilate and l-alanine, while l-kynurenine is the substrate of many prokaryotic inducible kynureninases. The human enzyme was cloned with an N-terminal hexahistidine tag, expressed, and purified from a bacterial expression system using Ni metal ion affinity chromatography. Kinetic characterization of the recombinant enzyme reveals classic Michaelis-Menten behavior, with a Km of 28.3 +/- 1.9 microM and a specific activity of 1.75 micromol min-1 mg-1 for 3-hydroxy-dl-kynurenine. Crystals of recombinant kynureninase that diffracted to 2.0 A were obtained, and the atomic structure of the PLP-bound holoenzyme was determined by molecular replacement using the Pseudomonas fluorescens kynureninase structure (PDB entry 1qz9) as the phasing model. A structural superposition with the P. fluorescens kynureninase revealed that these two structures resemble the "open" and "closed" conformations of aspartate aminotransferase. The comparison illustrates the dynamic nature of these proteins' small domains and reveals a role for Arg-434 similar to its role in other AAT alpha-family members. Docking of 3-hydroxy-l-kynurenine into the human kynureninase active site suggests that Asn-333 and His-102 are involved in substrate binding and molecular discrimination between inducible and constitutive kynureninase substrates.
| S-EPMC2531291 | biostudies-literature
Project description:RNA extracted at 240min. Samples are rRNA depleted. Expression measurement of Homo sapiens genes.
2019-07-31 | GSE114179 | GEO
Project description:Gene expression analysis in human focal cortical dysplasia and tuberous sclerosis
| PRJNA262955 | ENA